Sector News

Perrigo CFO resigns to take job at Amgen

February 28, 2017
Life sciences

A longtime member of Perrigo Co. PLC’s executive leadership team has resigned.

Judy L. Brown, who has been chief financial officer of the store-brand pharmaceuticals maker for nearly 11 years, has resigned to take another position.

While Perrigo stated that Brown “will take a position with another company in the pharmaceutical industry, beginning on April 1, 2017,” it did not name the company.

The Wall Street Journal reported online Monday that she will join California-based pharmaceutical industry giant Amgen Inc. Brown will join Amgen to run its global business services unit and its global internal audit function, the Journal reported.

It stated that she told Perrigo’s management of her decision last week.

Accounting and finance veteran Ron Winowiecki, who has been with Perrigo for about eight years, has been named acting CFO by Perrigo CEO John T. Hendrickson.

In a press release, Hendrickson praised Brown’s work, saying, “Judy’s leadership has been instrumental in developing a high caliber finance team at Perrigo and assisted our efforts to drive growth across our global platform. On behalf of the Board of Directors and management, I would like to thank Judy for her contributions to Perrigo over her more than 15-year tenure with the Company, and wish her all the best in her future endeavors.”

Brown was named executive vice president and CFO in July 2006. Oversight of business operations was added to her responsibilities in May of 2016. She was vice president and corporate controller of the company from September of 2004 to July of 2006. Prior to that, she held various senior positions in finance and operations at Whirlpool Corp.

Perrigo said in its press release that it will conduct a thorough search to identify a new permanent chief financial officer, but Winowiecki would be a “key candidate” for the position.

Winowiecki has been Perrigo’s senior vice president in business finance since January 2014. Before that, he was vice president in treasury and accounting shared services from September of 2011 to December of 2013 and was corporate vice president and treasurer from October 2008 to August 2011.

Winowiecki has a bachelor’s degree in accounting from Hope College and a master’s degree in business administration from Western Michigan University.

Speaking of Winowiecki, Hendrickson said, “Ron has almost 30 years of accounting and finance experience, devoting nearly 15 years to leading global public company finance organizations in the capacities of corporate controller, treasurer and chief accounting officer, including eight years at Perrigo, most recently as senior vice president, business finance. I am confident that this will be a seamless transition and that Ron will provide Perrigo and our financial team with strong leadership. I look forward to continuing to work alongside Ron.”

Perrigo also announced Monday that Svend Andersen has been appointed executive vice president and president of Consumer Healthcare International. The CHCI segment comprises Perrigo’s branded consumer healthcare business as well as its legacy international businesses. He will report directly to Hendrickson and join Perrigo’s executive committee.

Source: MLive

comments closed

Related News

October 2, 2022

GSK names Julie Brown, a 25-year AstraZeneca veteran, its first woman CFO

Life sciences

Five years ago, GSK made headlines when it hired Emma Walmsley to become the first woman to run a major pharmaceutical company. Now the Big Pharma has brought in another woman to control the company’s finances. Julie Brown will be GSK’s next chief financial officer. Brown, currently the chief operating and financial officer at fashion and beauty brand Burberry Group, is set to replace Iain Mackay.

October 2, 2022

Moderna creates new launch preparation role, poaches Novartis exec as manufacturing lead

Life sciences

Moderna created a new role responsible for “building out the company’s organization to support its growing pipeline.” Starting first thing 2023, Juan Andres, Moderna’s manufacturing head, will step into this new role under the title president of strategic partnerships and enterprise expansion, the company said Thursday.

October 2, 2022

Torrent Pharma to acquire Curatio for $245.16m

Life sciences

The latest takeover is anticipated to boost the presence of Torrent in the dermatology segment. Indian company Torrent Pharmaceuticals has signed a definitive agreement for the complete acquisition of Curatio Healthcare for $245.16m (Rs20bn).